Built for @rockefelleruniv

Turn your social into search

Your Instagram could be working a lot harder.

We turn your posts into editorial stories that bring new search traffic to rockefeller.edu. Three of yours will be on this page.

Book a demo
New York1230 York Avenue
@rockefellerunivyour Instagram
rockefeller.eduyour website
rockefelleruniv Instagram

rockefelleruniv A large clinical trial led by Rockefeller's Michel Nussenzweig and Marina Caskey shows that long acting antibodies may work with the immune system to control HIV and help reduce the reservoir that would make lifelong treatment necessary. Last year, results from an HIV clinical trial showed that some participants maintained viral control for nearly two years without daily antiretroviral therapy. Now, a follow up study in @nature Medicine reveals how broadly neutralizing antibodies, or bNAbs, kept the virus in check, with lessons that may inform HIV therapy. “The antibodies appear to be teaching the immune system to control HIV,” says Nussenzweig. “It’s almost as if the participants’ own immune activity acts as a second component to the antibodies. Together, the bNAbs and the natural immune response seem to work together to corner the virus.” The latest findings point to a new strategy. using vaccination to prime the immune system to work with bNAbs, while designing novel antibody combinations that make it harder for HIV to develop resistance. This work was supported in part by Rockefeller's @snforg Institute for Global Infectious Disease Research. Learn more at the link in our bio. #science #research #immunology #HIVresearch #HIV #clinicaltrials #bNAbs #scienceforthebenefitofhumanity

Antibody trial suggests a path toward HIV control without daily treatment

A follow up study shows how long acting antibodies may work with the immune system to keep HIV in check.

KRUEGER JAMES G MD STAFF

How it works

Three simple steps

  1. 1

    You post

    Same as today. Nothing changes on Instagram.

  2. 2

    A draft appears

    We turn your post into a full story in your voice within the hour.

  3. 3

    You approve

    One click publishes it to rockefeller.edu. Nothing goes live without you.

Your stories

Three from your feed

Nothing was published anywhere. You decide that. Every word will come from your own posts, your own photos and your own treatments.

HIV Research · From your post

Antibody trial suggests a path toward HIV control without daily treatment

A follow up study shows how long acting antibodies may work with the immune system to keep HIV in check.

“A large clinical trial led by Rockefeller's Michel Nussenzweig and Marina Caskey shows that long acting antibodies may work with the immune system to control HIV and help reduce the reservoir that would make lifelong treatment necessary. Last year, results from an HIV clinical trial showed that some participants maintained viral control for nearly two years without daily antiretroviral therapy. Now, a follow up study in @nature Medicine reveals how broadly neutralizing antibodies, or bNAbs, kept the virus in check, with lessons that may inform HIV therapy. “The antibodies appear to be teaching the immune system to control HIV,” says Nussenzweig. “It’s almost as if the participants’ own immune activity acts as a second component to the antibodies. Together, the bNAbs and the natural immune response seem to work together to corner the virus.” The latest findings point to a new strategy. using vaccination to prime the immune system to work with bNAbs, while designing novel antibody combinations that make it harder for HIV to develop resistance. This work was supported in part by Rockefeller's @snforg Institute for Global Infectious Disease Research. Learn more at the link in our bio. #science #research #immunology #HIVresearch #HIV #clinicaltrials #bNAbs #scienceforthebenefitofhumanity”

Lab Leadership · From your post

Rockefeller teaches scientists the skills their training left out

A three day workshop this July tackled the parts of running a lab that no one grades in graduate school.

“Early career scientists quickly learn how to design rigorous experiments and interpret data. They’re seldom taught how to juggle projects, manage laboratories, or negotiate salaries. These essential skills were the focus of Managing Science & Scientists, a three day workshop held this July at Rockefeller, sponsored by the Dean’s Office and the Kellen Women’s Entrepreneurship Fund. The workshop was developed specifically for the university and led by faculty from Harvard Business School and UC Berkeley Haas School of Business, with the goal of introducing a cohort of early career researchers to evidence based approaches for addressing the professional realities of research. Learn more at the link in our bio.”

Graduate Research · From your post

Following curiosity from obesity to skin inflammation

A Rockefeller graduate student explains how a wide range of interests led her to study the link between obesity and inflammatory skin disease.

“Rockefeller grad student Natalie Alexander gravitated to science to feed her wide ranging curiosity. Now she’s investigating the connection between obesity and inflammation in skin. a focus she crafted by following her curiosity through different labs and scientific disciplines. “I have always had so many questions about the world, and science is a really practical way to answer those questions,” she says. “I also have a variety of interests, so the interdisciplinary nature of research at Rockefeller lets me not have to choose just one lane.” Learn more at the link in our bio. #science #research #inflammation #obesity #skindisease #gradstudents”

Same post.
New audience.
Real traffic.

One social post becomes another searchable entry point to Krueger James G MD.

2,875Organic clicks generated in 28 days
1,730Google AI citations in a single day
10 min/dayHuman editorial time to operate the system

Our own magazine. Clicks and citations from Google Search Console, as of September 15, 2026.

Want this for everything you post?

Book a demo